Association between time to progression and subsequent survival inceritinib-treated patients with advanced ALK-positive non-small-cell lung cancer.

CONCLUSIONS: A longer duration of TTP after treatment with ceritinib was significantly associated with a longer duration of both PPS and OS.
PMID: 27488695 [PubMed - in process]

Source: Current Medical Research and Opinion - October 20, 2016 Category: Research Tags: Curr Med Res Opin Source Type: research